Science & Technology
CSIR's cancer drug enters clinical trials
June 08, 2020
A CSIR lab has received approval to conduct clinical trials of a new drug in pancreatic cancer patients.
Indian Institue of Integrative Medicine, Jammu is a drug research laboratory that works under the Council of Scientific & Industrial Research.
This approval has been given by the New Drugs Division of Central Drugs Standard Control Organization (CDSCO).
This drug has been created using the content from the leaves of Indian white cedar.
Globally, pancreatic cancer causes more than 2.5 lakh deaths annually.
This cancer is considered as one of the untreatable cancer types, because of its very late diagnosis.
Central Drugs Standard Control Organisation
Jammu and Kashmir
Council of Scientific & Industrial Research
Lieutenant Governor over-rules Delhi Government decision for hospital reservation
9 June: World Accreditation Day
NCL Pune develops indigenous nasopharyngeal swabs
June 06, 2020
Union Minister inaugurates seed processing plant in Jammu and Kashmir
June 26, 2021
Mawya Sudan becomes first female fighter pilot from J&K
June 23, 2021
Medical devices to be regulated under Drugs and Cosmetics Act
February 12, 2020
Girish Chandra Murmu becomes first Lieutenant Governor of J&K
November 01, 2019
World's first 3D printed steel bridge opened in Amsterdam
July 24, 2021
© 2021, All Rights Reserved.